Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
11.17
-0.02 (-0.18%)
At close: Aug 8, 2025, 4:00 PM
11.16
-0.01 (-0.09%)
After-hours: Aug 8, 2025, 6:03 PM EDT
AY Market Cap
Dyne Therapeutics has a market cap or net worth of $1.59 billion as of August 8, 2025. Its market cap has decreased by -63.40% in one year.
Market Cap
1.59B
Enterprise Value
1.02B
1-Year Change
-63.40%
Ranking
Category
Stock Price
$11.17
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $1.59B, an increase of 100.74%. That is a compound annual growth rate of 15.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 1.59B | -33.78% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | 954.35M | 20.67% |
| Sep 17, 2020 | 790.90M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 561.67B |
| Johnson & Johnson | 417.44B |
| AbbVie | 349.87B |
| Abbott Laboratories | 233.71B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 227.59B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |